Sign In
Buy QGEN
$36.45
+0.760 (+2.13%)
At Close: Jun 03, 2026
QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing
05:05pm, Tuesday, 28'th Oct 2025
VENLO, Netherlands, & GERMANTOWN, Maryland--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 4,000th placement of its QIAcube Connect instrumen
Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for
11:08am, Tuesday, 28'th Oct 2025
Qiagen (QGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yousif Capital Management LLC Has $301,000 Stake in QIAGEN N.V. $QGEN
03:48am, Friday, 24'th Oct 2025
Yousif Capital Management LLC lifted its position in shares of QIAGEN N.V. (NYSE: QGEN) by 3.7% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securitie
QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast
08:24am, Monday, 13'th Oct 2025
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the third quarter of 2025. Press release date / time: Tuesday
QGEN vs. ACAD: Which Stock Is the Better Value Option?
12:41pm, Thursday, 09'th Oct 2025
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Qiagen (QGEN) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more attractive to value inv
Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript
10:57am, Thursday, 25'th Sep 2025
Qiagen N.V. (NYSE:QGEN ) Bank of America Global Healthcare Conference 2025 September 25, 2025 5:45 AM EDT Company Participants John Gilardi - VP & Head of Corporate Communications Conference Call Part
QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio
04:05pm, Wednesday, 10'th Sep 2025
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has achieved CE-IVDR certification for its full portfolio of QIAstat-D
Qiagen N.V. (QGEN) Presents At Baird Global Healthcare Conference 2025 Prepared Remarks Transcript
04:03pm, Wednesday, 10'th Sep 2025
Qiagen N.V. (NYSE:QGEN ) Baird Global Healthcare Conference 2025 September 10, 2025 1:25 PM EDT Company Participants Roland Sackers - CFO, MD & Member of Management Board John Gilardi - VP & Head of C
Qiagen N.V. (QGEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
05:01pm, Tuesday, 09'th Sep 2025
Qiagen N.V. (NYSE:QGEN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT Company Participants Roland Sackers - CFO, MD & Member of Management Board John Gilardi -
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing
01:30am, Tuesday, 02'nd Sep 2025
GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAstat‑Dx Rise – a version of the QI
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds
05:08pm, Thursday, 28'th Aug 2025
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICT
QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds
12:11pm, Thursday, 28'th Aug 2025
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICT
QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds
02:05am, Thursday, 28'th Aug 2025
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICT
Qiagen: Diagnostics Vs. Life Sciences Pair Trade Analysis
09:52am, Thursday, 21'st Aug 2025
Diagnostics now outperform Life Sciences due to academic funding cuts, making Qiagen's defensive profile more attractive in the current market. Qiagen offers stable growth, high profitability, and low
Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention
10:21am, Monday, 11'th Aug 2025
Examine the evolution of Qiagen's (QGEN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
